Elevated ABCB1 Expression Confers Acquired Resistance to Aurora Kinase Inhibitor GSK-1070916 in Cancer Cells

The emergence of multidrug resistance (MDR) has been a major issue for effective cancer chemotherapy as well as targeted therapy. One prominent factor that causes MDR is the overexpression of ABCB1 transporter. In the present study, we revealed that the Aurora kinase inhibitor GSK-1070916 is a subst...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhuo-Xun, Yang, Yuqi, Wang, Jing-Quan, Zhou, Wen-Min, Chen, Junyu, Fu, Yi-Ge, Patel, Ketankumar, Chen, Zhe-Sheng, Zhang, Jian-Ye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841342/
https://www.ncbi.nlm.nih.gov/pubmed/33519482
http://dx.doi.org/10.3389/fphar.2020.615824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841342/
https://www.ncbi.nlm.nih.gov/pubmed/33519482
http://dx.doi.org/10.3389/fphar.2020.615824

Ejemplares similares